Screener
Gilead Sciences GILD Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi.
The source filing: Gilead Sciences’s 10-K, filed February 24, 2026. Open the filing →
- Filed
- Feb 24, 2026, 4:18 PM EST
- Fiscal year
- FY2025
- Accession
- 0000882095-26-000006
FAQ
- What is Gilead Sciences's net gains (losses) on investments?
- Gilead Sciences (GILD) reported net gains (losses) on investments of $253M in Q4 2025.
- How has Gilead Sciences's net gains (losses) on investments changed year-over-year?
- Gilead Sciences's net gains (losses) on investments increased by 300.8% year-over-year, from -$126M to $253M.
- What is the long-term trend for Gilead Sciences's net gains (losses) on investments?
- Over 2 years (2021 to 2025), Gilead Sciences's net gains (losses) on investments has grown at a -14.0% compound annual growth rate (CAGR), from -$610M to $451M.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.
Ask your AI about Gilead Sciences's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude